QTTB
QTTB clinical trials: Q32 Bio Inc.
Every trial on ClinicalTrials.gov where Q32 Bio Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
QTTB on the catalyst calendar · QTTB registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jun 2026Sponsor estimate | NCT06018428A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)Q32 Bio Inc. · Alopecia Areata | QTTBLead | Phase 2 | Active, not recruiting | Locked | Locked | Locked |
| Dec 2024Sponsor estimate | NCT05509023Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)Q32 Bio Inc. · Atopic Dermatitis | QTTBLead | Phase 2 | Active, not recruiting | Locked | Locked | Locked |
| Jan 12, 2022Actual | NCT04485481Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult VolunteersQ32 Bio Inc. · Safety Issues | QTTBLead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Jun 2026Sponsor estimatePhase 2NCT06018428A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)Q32 Bio Inc. · Alopecia AreataActive, not recruitingQTTBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2024Sponsor estimatePhase 2NCT05509023Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)Q32 Bio Inc. · Atopic DermatitisActive, not recruitingQTTBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 12, 2022ActualPhase 1NCT04485481Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult VolunteersQ32 Bio Inc. · Safety IssuesCompletedQTTBLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner